AlphaMadera's AlphaVal page computes Curtiss-Wright Corporation's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag CW as undervalued, fairly valued, or overvalued.

What is Curtiss-Wright Corporation's fair value?

Fair value for CW is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value CW?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from CW's most recent reported fundamentals.

CW - Curtiss-Wright Corporation

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $775.50 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 70% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Strong

Trading 60.7% above fair value

Current Price $740.06

Bear Case $305.82 58.7% downside ($305.82 - $740.06) / $740.06 = -58.7% 8% stage 1 growth, 11% discount

Fair Value $460.53 37.8% downside ($460.53 - $740.06) / $740.06 = -37.8% 13% stage 1 growth, 11% discount

Bull Case $622.86 15.8% downside ($622.86 - $740.06) / $740.06 = -15.8% 16% stage 1 growth, 11% discount

Adjust Assumptions

DCF Stage 1 Growth Rate

12.6%

Discount Rate (WACC)

11.0%

Terminal Growth Rate

3.0%

Key Value Driver

FCF growth rate (13% base case)

Terminal Value % of EV 41%

Implied Market Multiple 52.6x

Market is pricing in (growth) 21.9% vs our 12.6% base

Plain-Language Summary

Our base-case estimate uses a two-stage discounted cash flow model based on free cash flow. We then blend that result with the average analyst price target of $775.50 from 25 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $460.53 per share.

Warnings

ℹ Wall Street's average price target is $775.50 (from 25 analysts). Our estimate is 54% below the consensus -- consider that gap carefully.

Key Risks

P/E alone misleads — earnings depressed by growth investment
Cyclical or commodity businesses may be misclassified as platforms
Terminal value dominance suggests sensitivity to long-run assumptions